JP2004535417A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535417A5
JP2004535417A5 JP2003501278A JP2003501278A JP2004535417A5 JP 2004535417 A5 JP2004535417 A5 JP 2004535417A5 JP 2003501278 A JP2003501278 A JP 2003501278A JP 2003501278 A JP2003501278 A JP 2003501278A JP 2004535417 A5 JP2004535417 A5 JP 2004535417A5
Authority
JP
Japan
Prior art keywords
composition
atp
weight percent
gastric acid
acid secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003501278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004535417A (ja
Filing date
Publication date
Priority claimed from US10/162,143 external-priority patent/US20030069203A1/en
Application filed filed Critical
Publication of JP2004535417A publication Critical patent/JP2004535417A/ja
Publication of JP2004535417A5 publication Critical patent/JP2004535417A5/ja
Withdrawn legal-status Critical Current

Links

JP2003501278A 2001-06-04 2002-06-04 アデノシン三リン酸の投与により筋疲労を低減させる方法 Withdrawn JP2004535417A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29570501P 2001-06-04 2001-06-04
US10/162,143 US20030069203A1 (en) 2001-06-04 2002-06-03 Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
PCT/US2002/017835 WO2002098226A1 (en) 2001-06-04 2002-06-04 Method for reducing muscle fatigue through administration of adenosine triphosphate

Publications (2)

Publication Number Publication Date
JP2004535417A JP2004535417A (ja) 2004-11-25
JP2004535417A5 true JP2004535417A5 (https=) 2006-01-05

Family

ID=26858483

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003501278A Withdrawn JP2004535417A (ja) 2001-06-04 2002-06-04 アデノシン三リン酸の投与により筋疲労を低減させる方法

Country Status (6)

Country Link
US (1) US20030069203A1 (https=)
EP (1) EP1406495A1 (https=)
JP (1) JP2004535417A (https=)
KR (1) KR20040032821A (https=)
CA (1) CA2449712A1 (https=)
WO (1) WO2002098226A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5032310B2 (ja) * 2005-05-27 2012-09-26 興和株式会社 疲労回復のための医薬
US20070203091A1 (en) * 2006-02-28 2007-08-30 Eliezer Rapaport Methods and therapeutic compositions for improving liver, blood flow and skeletal muscle functions in advanced diseases and aging
JPWO2007132718A1 (ja) * 2006-05-12 2009-09-24 興和株式会社 アデノシン5´三リン酸又は生理学的に許容されるその塩を含有する固形製剤
TW200812601A (en) * 2006-05-30 2008-03-16 Kowa Co Medicine for recovering from fatigue
WO2008001494A1 (en) * 2006-06-27 2008-01-03 Kowa Co., Ltd. Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue
US11628807B2 (en) * 2019-09-17 2023-04-18 GM Global Technology Operations LLC Track-guided wiper system and method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819830A (en) * 1971-07-01 1974-06-25 Dainippon Pharmaceutical Co Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
JPH01308231A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 安定化された医薬組成物および製造法
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
GB9724813D0 (en) * 1997-11-25 1998-01-21 Univ Nottingham Reducing muscle fatigue
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
EP1221945A4 (en) * 1999-10-20 2005-06-15 Eliezer Rapaport METHOD AND PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS FOR THE ADMINISTRATION OF ADENOSINE
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US6399116B1 (en) * 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof

Similar Documents

Publication Publication Date Title
IL180943A (en) Multiparticle pharmaceutical dosage form for a low-soluble active substances and method for producing said pharmaceutical dosage form
CA2407072A1 (en) Taste masking coating composition
ATE531368T1 (de) Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
ATE152617T1 (de) Pulverförmige, stabilisierte wirkstoffe, diese enthaltende zusammensetzungen verfahren zu ihrer herstellung und ihre verwendung
CY1105908T1 (el) Στοματικως αποσαθρουμενα δισκια που πepιλαμβανουν βενζιμιδαζολιο
DE60335456D1 (de) Absorbierende Artikel enthaltend beschichtete superabsorbierende Partikel
WO2007086914A3 (en) Nanoparticulate clopidogrel formulations
JP2000109426A (ja) 薬剤的に活性な粒子の調製方法
BR9806738A (pt) Composição farmacêutica de fenofibrato dotada de alta biodisponibilidade, e método para a sua preparação.
JP2002356654A5 (https=)
HU228895B1 (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
CA2561109A1 (en) Gastric retention system
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
JP2009521419A5 (https=)
JP2008510764A5 (https=)
JP2004535417A5 (https=)
GEP20043285B (en) Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
RU2008130171A (ru) Маскирование вкуса порошков
EP1368002A2 (fr) Procede de fabrication d'un comprime flottant incluant de l'alfuzosine
WO2007022022A3 (en) Volumizing agents
Yassin et al. Aceclofenac-loaded microspheres prepared by vesicular ionotropic gelation to minimize drug-induced gastric ulcers in rats
WO1999042087A3 (en) Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
JPH11502201A (ja) 医薬用マトリックスペレット、錠剤およびそれらの製造用組成物
WO2006034397A3 (en) Coating composition
JP2002194264A5 (https=)